Early learnings from a national trial of a consumer and clinician developed survivorship care intervention for men with prostate cancer on androgen deprivation therapy (PCEssentials Hormone Therapy Study)

被引：0
|
作者：
Green, A. [1 ]
Newton, R. U. [2 ]
Chambers, S. [3 ]
Smith, D. P. [4 ]
Tuffaha, H. [5 ]
Galvao, D. A. [2 ]
Heathcote, P. [6 ]
Patel, M., I [7 ]
Christie, D. [8 ]
Egger, S. [4 ]
Sara, S. A. [9 ]
Heneka, N. [1 ]
Dunn, J. [9 ]
机构：
[1] Univ Southern Queensland UniSQ Ipswich, Ipswich, Qld, Australia
[2] Edith Cowan Univ, Joondalup, Australia
[3] Australian Catholic Univ, Brisbane Campus, Banyo, Australia
[4] Univ Sydney, Daffodil Ctr, Sydney, NSW, Australia
[5] Univ Queensland, Brisbane, Qld, Australia
[6] Brisbane Urol Clin, Brisbane, Qld, Australia
[7] Univ Sydney, Sydney, NSW, Australia
[8] Genesiscare, Gold Coast, Australia
[9] Prostate Canc Fdn Australia, St Leonards, NSW, Australia
来源：
INTERNATIONAL JOURNAL OF CANCER | 2024年 / 155卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
000333
引用
收藏
页码：113 / 113
页数：1
相关论文
共 50 条
  • [31] Effects of a lifestyle intervention on endothelial function in men on long-term androgen deprivation therapy for prostate cancer
    Gilbert, Stephen E.
    Tew, Garry A.
    Fairhurst, Caroline
    Bourke, Liam
    Saxton, John M.
    Winter, Edward M.
    Rosario, Derek J.
    BRITISH JOURNAL OF CANCER, 2016, 114 (04) : 401 - 408
  • [32] Systemic Therapy for the Treatment of Hormone-Sensitive Metastatic Prostate Cancer: from Intermittent Androgen Deprivation Therapy to Chemotherapy
    Liaw, Bobby C.
    Shevach, Jeffrey
    Oh, William K.
    CURRENT UROLOGY REPORTS, 2015, 16 (03)
  • [33] Systemic Therapy for the Treatment of Hormone-Sensitive Metastatic Prostate Cancer: from Intermittent Androgen Deprivation Therapy to Chemotherapy
    Bobby C. Liaw
    Jeffrey Shevach
    William K. Oh
    Current Urology Reports, 2015, 16
  • [34] Phase 3 Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Metastatic Hormone-Sensitive Prostate Cancer: the ARCHES Trial
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (04) : 10 - 12
  • [35] UPDATE ON ANDROGEN DEPRIVATION THERAPY AND ADJUVANT METFORMIN (ADMET) TRIAL FOR MEN WITH TREATMENT NAIVE METASTATIC PROSTATE CANCER
    Rhee, Handoo
    Gunter, J.
    Jovanovic, L.
    Williams, E.
    Hollier, B.
    Vela, I.
    Wood, S.
    Ho, K.
    Nelson, C.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 40 - 41
  • [36] Risk of colorectal adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer; a nationwide cohort study
    Shore, Richard
    Zhang, Ji
    Ye, Weimin
    Stattin, Par
    Lindblad, Mats
    CANCER CAUSES & CONTROL, 2023, 34 (11) : 949 - 961
  • [37] Phase II Study of Ipilimumab in Men With Metastatic Prostate Cancer With an Incomplete Response to Androgen Deprivation Therapy
    Graff, Julie N.
    Stein, Mark N.
    Surana, Rishi
    Al Rabadi, Luai
    Liu, Eric
    Fong, Lawrence
    Bailey, Shawna
    Latour, Emile
    Newby, Timothy A.
    Moran, Amy E.
    Beer, Tomasz M.
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [38] Depression, Anxiety, and Patterns of Mental Health Care Among Men With Prostate Cancer Receiving Androgen Deprivation Therapy
    Tsao, Phoebe A.
    Ross, Ryan D.
    Bohnert, Amy S. B.
    Mukherjee, Bhramar
    Caram, Megan E., V
    ONCOLOGIST, 2022, 27 (04): : 314 - 322
  • [39] Depression, anxiety, and patterns of mental health care among men with prostate cancer on androgen deprivation therapy (ADT).
    Tsao, Phoebe A.
    Ross, Ryan
    Bohnert, Amy S. B.
    Mukherjee, Bhramar
    Caram, Megan Veresh
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [40] A descriptive study of experienced burden by spouses living with men undergoing androgen deprivation therapy for prostate cancer
    Avlastenok, Jeanne L.
    Rud, Kirsten
    Koppen, Helle
    Fons, Lillian
    Ostergren, Peter
    SCANDINAVIAN JOURNAL OF UROLOGY, 2017, 51 : 50 - 51
12345